MYRIAD GENETICS, INC. Goodwill, Acquired During Period
MYRIAD GENETICS, INC. (MYGN) reported Goodwill, Acquired During Period of $48.70 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Notes › Intangible Assets › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2023-03-01
- MYRIAD GENETICS, INC. goodwill, acquired during period for the quarter ending 2019-06-30 was -$3.40M.
- MYRIAD GENETICS, INC. goodwill, acquired during period for the quarter ending 2019-03-31 was $3.20M.
- MYRIAD GENETICS, INC. goodwill, acquired during period for the quarter ending 2018-12-31 was $200.00K.
- MYRIAD GENETICS, INC. goodwill, acquired during period for the quarter ending 2018-09-30 was $94.90M.
- MYRIAD GENETICS, INC. goodwill, acquired during period for fiscal 2022 was $48.70M.
- MYRIAD GENETICS, INC. goodwill, acquired during period for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- MYRIAD GENETICS, INC. goodwill, acquired during period for fiscal 2019 was $94.90M.
- MYRIAD GENETICS, INC. goodwill, acquired during period for fiscal 2017 was $116.30M, a 557.06% increase from fiscal 2016.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month | Goodwill, Acquired During Period 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $48.70M 10-K · filed 2023-03-01 | ||||
| 2020-06-30 | $0.00 10-KT · filed 2021-03-16 | ||||
| 2019-06-30 | -$3.40M derived: 10-KT 12 month − 10-Q 9 month · filed 2021-03-16 | -$200.00K derived: sum of 2 quarters · filed 2021-03-16 | $0.00 derived: sum of 3 quarters · filed 2021-03-16 | $94.90M 10-KT · filed 2021-03-16 | |
| 2019-03-31 | $3.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-08 | $3.40M derived: sum of 2 quarters · filed 2019-05-08 | $98.30M 10-Q · filed 2019-05-08 | ||
| 2018-12-31 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-06 | $95.10M 10-Q · filed 2019-02-06 | |||
| 2018-09-30 | $94.90M 10-Q · filed 2018-11-07 | ||||
| 2017-06-30 | -$3.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-24 | -$4.20M derived: sum of 2 quarters · filed 2018-08-24 | $0.00 derived: sum of 3 quarters · filed 2018-08-24 | $116.30M 10-K · filed 2018-08-24 | |
| 2017-03-31 | -$800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-03 | $3.40M derived: sum of 2 quarters · filed 2017-05-03 | $119.70M 10-Q · filed 2017-05-03 | ||
| 2016-12-31 | $4.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-08 | $120.50M 10-Q · filed 2017-02-08 | |||
| 2016-09-30 | $116.30M 10-Q · filed 2016-11-02 | ||||
| 2016-06-30 | $17.70M 10-K · filed 2017-08-09 | ||||
| 2015-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-03 | $0.00 10-Q · filed 2016-02-03 | -$8.48M derived: sum of 3 quarters · filed 2016-08-10 | ||
| 2015-09-30 | $0.00 10-Q · filed 2015-11-04 | -$8.48M derived: sum of 2 quarters · filed 2016-08-10 | |||
| 2015-06-30 | -$8.48M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-10 | $8.10M 10-K · filed 2016-08-10 | |||
| 2015-03-31 | $16.58M 10-Q · filed 2015-05-06 | ||||
| 2014-06-30 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-12 | $112.30M 10-K · filed 2015-08-12 | $112.33M 10-K · filed 2014-08-13 | ||
| 2014-03-31 | $109.90M 10-Q · filed 2014-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |